These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 4025111

  • 21. Electrophysiological effects of left ventricular hypertrophy. Effect of calcium and potassium channel blockade.
    Kowey PR, Friechling TD, Sewter J, Wu Y, Sokil A, Paul J, Nocella J.
    Circulation; 1991 Jun; 83(6):2067-75. PubMed ID: 1645624
    [Abstract] [Full Text] [Related]

  • 22. Influence of site of stimulation on measurement of ventricular vulnerability in the normal and ischemic feline heart.
    Kowey PR, Friehling TD, Wetstein L, O'Connor KM, Kelliher GJ.
    Am J Cardiol; 1984 Aug 01; 54(3):421-3. PubMed ID: 6465027
    [Abstract] [Full Text] [Related]

  • 23. Effect of bretylium tosylate on ventricular fibrillation threshold during hypothermia in dogs.
    Bjørnstad H, Mortensen E, Sager G, Refsum H.
    Am J Emerg Med; 1994 Jul 01; 12(4):407-12. PubMed ID: 8031422
    [Abstract] [Full Text] [Related]

  • 24. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E, Gibson JK.
    Circulation; 1981 Nov 01; 64(5):1045-50. PubMed ID: 7285294
    [Abstract] [Full Text] [Related]

  • 25. Cardiac arrhythmias produced by bretylium in cats anesthetized with halothane.
    Condouris GA, Ortiz J, Lyness W.
    Eur J Pharmacol; 1979 Apr 01; 55(1):93-7. PubMed ID: 35358
    [Abstract] [Full Text] [Related]

  • 26. Arrhythmia inducibility and ventricular vulnerability in a chronic feline infarction model.
    Wetstein L, Mark R, Kelliher GJ, Friehling T, O'Connor KM, Kowey PR.
    Am Heart J; 1985 Nov 01; 110(5):955-60. PubMed ID: 4061270
    [Abstract] [Full Text] [Related]

  • 27. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
    Patterson E, Gibson JK, Lucchesi BR.
    J Pharmacol Exp Ther; 1981 Mar 01; 216(3):453-8. PubMed ID: 7205624
    [No Abstract] [Full Text] [Related]

  • 28. Prevention of ventricular fibrillation during hypothermia with bretylium tosylate.
    Buckley JJ, Bosch OK, Bacaner MB.
    Anesth Analg; 1971 Mar 01; 50(4):587-93. PubMed ID: 5105113
    [No Abstract] [Full Text] [Related]

  • 29. Acute electrophysiologic effects and antiarrhythmic/antifibrillatory activity of intravenous amiodarone in a chronic feline infarction model.
    Marinchak RA, O'Connor KM, Friehling TD, Kowey PR.
    J Cardiovasc Pharmacol; 1989 Sep 01; 14(3):389-95. PubMed ID: 2476617
    [Abstract] [Full Text] [Related]

  • 30. Management of ventricular dysrhythmias in the prehospital and emergency department setting.
    Mayer NM.
    Am J Cardiol; 1984 Jul 30; 54(2):34A-36A. PubMed ID: 6464998
    [Abstract] [Full Text] [Related]

  • 31. The differential response of normal and ischaemic Purkinje fibres to clofilium, d-sotalol and bretylium.
    Gough WB, el-Sherif N.
    Cardiovasc Res; 1989 Jun 30; 23(6):554-9. PubMed ID: 2590928
    [Abstract] [Full Text] [Related]

  • 32. Bretylium tosylate in patients with acute myocardial infarction.
    Torresani J.
    Am J Cardiol; 1984 Jul 30; 54(2):20A-25A. PubMed ID: 6464996
    [Abstract] [Full Text] [Related]

  • 33. Rationale of therapy in the patient with acute myocardial infarction and life-threatening arrhythmias: a focus on bretylium.
    Lucchesi BR.
    Am J Cardiol; 1984 Jul 30; 54(2):14A-19A. PubMed ID: 6380259
    [Abstract] [Full Text] [Related]

  • 34. The influence of prostacyclin on coronary occlusion induced arrhythmia in cats.
    Dix RK, Kelliher GJ, Jurkiewicz N, Lawrence T.
    Prostaglandins Med; 1979 Sep 30; 3(3):173-84. PubMed ID: 399533
    [Abstract] [Full Text] [Related]

  • 35. Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
    Lombardi F, Verrier RL, Lown B.
    Am Heart J; 1983 Jun 30; 105(6):958-65. PubMed ID: 6858844
    [Abstract] [Full Text] [Related]

  • 36. Lack of effect of bretylium tosylate on electrical ventricular defibrillation in a controlled study.
    Koo CC, Allen JD, Pantridge JF.
    Cardiovasc Res; 1984 Dec 30; 18(12):762-7. PubMed ID: 6518459
    [Abstract] [Full Text] [Related]

  • 37. Mechanisms underlying the development of ventricular fibrillation during early myocardial ischemia.
    Pogwizd SM, Corr PB.
    Circ Res; 1990 Mar 30; 66(3):672-95. PubMed ID: 2306802
    [Abstract] [Full Text] [Related]

  • 38. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release.
    Corbalan R, Verrier RL, Lown B.
    Am Heart J; 1976 Aug 30; 92(2):223-30. PubMed ID: 941834
    [Abstract] [Full Text] [Related]

  • 39. Antifibrillatory effects of clofilium in the rabbit isolated heart.
    Friedrichs GS, Chi L, Green AL, Lucchesi BR.
    Br J Pharmacol; 1994 Sep 30; 113(1):209-15. PubMed ID: 7812612
    [Abstract] [Full Text] [Related]

  • 40. The action of reserpine, 6-hydroxydopamine, and bretylium on digitalis-induced cardiotoxicity.
    Lathers CM, Gerard-Ciminera JL, Baskin SI, Krusz JC, Kelliher GJ, Roberts J.
    Eur J Pharmacol; 1981 Dec 17; 76(4):371-9. PubMed ID: 6799304
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.